The best performing protein biomarker, CXCL1 had high sensitivity and specificity to diagnose HIV-negative, adults with ATB in high burden countries (South Africa and Vietnam), and discriminate those patients from the important clinical differential diagnoses: LTBI and non-TB lung disease. This evidence concerns the gene CXCL1 and lung disorder.